Aberdare Ventures

Aberdare Ventures

Signal active

Investment Firm

Overview

Aberdare Ventures is a venture firm that focuses on a limited number of entrepreneurial teams committed to building leading healthcare technology companies. They limit their commitments in the belief that their involvement can increase the probability of success for their portfolio companies and generate greater returns for their investors.

Highlights

Founded

1999

Industry

Venture Capital

Employees

11-50

Investment

72

Lead Investment

7

Exits

22

Stages

Late Stage Venture, Early Stage Venture, Seed, Private Equity

Investor Type

Venture Capital

Location

San Francisco, California, United States, North America

Contact Information

Social

Profile Resume

Aberdare Ventures, established in 1999 and headquartered in United States, North America., specializes in Late Stage Venture, Early Stage Venture, Seed, Private Equity investments across Biotechnology, Health Care, Pharmaceutical, Financial Services, Venture Capital, Finance, Consumer, Medical, Fitness, Health Diagnostics. The organization boasts a portfolio of 72 investments, with an average round size of $20.2M and 22 successful exits. Their recent investments include Anacor Pharmaceutical, Rho Capital Partners, Venrock, Care Capital, GSK. The highest investment round they participated in was $105.7B. Among their most notable exits are Anacor Pharmaceutical and Rho Capital Partners. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Paul Klingenstein

Paul Klingenstein

Managing Partner

imagePlace Sigrid Van Bladel, PhD

Sigrid Van Bladel, PhD

Venture Partner

imagePlace Judy Stralka

Judy Stralka

Administrator

imagePlace Maureen Valentini

Maureen Valentini

Bookkeeper

imagePlace Christina Fong

Christina Fong

Controller

Investment portfolio

Aberdare Ventures has made 72 investments. Their most recent investment was on Sep 05, 2018, when Cricket Health raised $24.0M.

Aberdare Ventures has made 9 diversity investments. Their most recent diversity investment was on Nov 28, 2012, when Wello raised $1.0M.

investments

72

Diversity investments

9

Lead investments

7

Number of exits

22

Investments

72

Annouced DateOrganization NameIndustryMoney Raised
Jun 25, 2015
Realeve Realeve
Health Care43.2M
Jul 19, 2017
Gravia Gravia
Wholesale14.1M
Aug 20, 2018
MC10 MC10
Semiconductor10.0M
Sep 05, 2018
Cricket Health Cricket Health
Health Care24.0M

Exits

22

Funding Timeline

Funding rounds

72

Investors

0

Funds

1

Funding Rounds

72

Aberdare Ventures has raised 72 rounds. Their latest funding was raised on Sep 05, 2018 from a Series A - Cricket Health round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Jun 25, 2015
Series D - Realeve Series D - Realeve
-43.2M-
Jul 19, 2017
Series C - Gravia Series C - Gravia
-14.1M-
Aug 20, 2018
Venture Round - MC10 Venture Round - MC10
-10.0M-
Sep 05, 2018
Series A - Cricket Health Series A - Cricket Health
-24.0M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries